SAR — Sareum Holdings Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Notice of AGM, Annual Report and Accounts
Brief: Sareum Holdings Initiates Food Effects Study In Phase 1a Trial For Sdc-1801
Director Dealings
Exercise of Share Options and Director Dealings
Brief: Sareum Holdings Says Loss For Year To 30 June 2023 Was £3.2 Mln After Tax
Final Results for the Year Ended 30 June 2023
Director's Dealing
Director Dealing
Brief: Sareum Holdings Says Loss For Year To 30 June 2023 Expected To Be Around £3.3 MLN After Tax
Update on financial and operational progress
Brief: Sareum Holdings Says Equity Prepayment Facility Of Up To £5 Mln
Brief: Sareum Holdings PLC Says Dosing Commences In Phase 1A Trial Of SDC-801
Dosing commences in Phase 1a trial of SDC-801
Brief: Sareum Holdings Announces Commencement Of A Phase 1a Clinical Trial For SDC-1801
Brief: Sareum Holdings PLC Receives Approval To Initiate Phase 1 Clinical Trial
Approval to initiate Phase 1 clinical trial
Brief: Sareum Holdings Reports Cash At 31 December 2022 Of £2.9M
Half-Year Report
Brief: Sareum Holdings Provides Update On SDC-1801